Thus, increased levels of IGFBP7 and TIMP2 could serve as useful biomarkers for kidney involvement and the early detection of renal impairment, enabling timely intervention for better management of renal complications in MM patients. Here, IGFBP7 is linked to Miyoshi myopathy.